Significance of murine retroviral mutagenesis for identification of disease genes in human acute myeloid leukemia

Cancer Research

Volumn 66, Issue 2, 2006, Pages 622-626

  Erkeland, Stefan J ^a   Verhaak, Roel G W ^a   Valk, Peter J M ^a   Delwel, Ruud ^a   Löwenberg, Bob ^a   Touw, Ivo P ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CANCER GENETICS; CYTOGENETICS; GENE EXPRESSION PROFILING; GENE INSERTION; GENE MUTATION; GENETIC LINKAGE; HUMAN; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; PROTO ONCOGENE; RETROVIRUS; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; VIRUS DNA CELL DNA INTERACTION;

ACUTE DISEASE; ADULT; ANIMALS; CHILD; GENE EXPRESSION PROFILING; HUMANS; LEUKEMIA, MYELOID; MICE; MUTAGENESIS, INSERTIONAL; PROTO-ONCOGENES; RETROVIRIDAE; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC;

EID: 31544447174     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-05-2908     Document Type: Article

References (20)

1. Jonkers J, Berns A. Retroviral insertional mutagenesis as a strategy to identify cancer genes. Biochim Biophys Acta 1996;1287:29-57.
2. Suzuki T, Shen H, Akagi K, et al. New genes involved in cancer identified by retroviral tagging. Nat Genet 2002;32:166-74.
3. Erkeland SJ, Valkhof M, Heijmans-Antonissen C, et al. Large-scale identification of disease genes involved in acute myeloid leukemia. J Virol 2004;78:1971-80.
4. Joosten M, Vankan-Berkhoudt Y, Tas M, et al. Largescale identification of novel potential disease loci in mouse leukemia applying an improved strategy for cloning common virus integration sites. Oncogene 2002;21:7247-55.
5. Mikkers H, Allen J, Knipscheer P, et al. High-throughput retroviral tagging to identify components of specific signaling pathways in cancer. Nat Genet 2002;32:153-9.
6. Li J, Shen H, Himmel KL, et al. Leukaemia disease genes: large-scale cloning and pathway predictions. Nat Genet 1999;23:348-53.
7. Neil JC, Cameron ER. Retroviral insertion sites and cancer: fountain of all knowledge? Cancer Cell 2002;2:253-5.
8. Bullinger L, Dohner K, Bair E, et al. Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia. N Engl J Med 2004;350:1605-16.
9. Ross ME, Mahfouz R, Onciu M, et al. Gene expression profiling of pediatric acute myelogenous leukemia. Blood 2004;104:3679-87.
10. Valk PJ, Verhaak RG, Beijen MA, et al. Prognostically useful gene-expression profiles in acute myeloid leukemia. N Engl J Med 2004;350:1617-28.
11. Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A 2001;98:5116-21.
12. Akagi K, Suzuki T, Stephens RM, Jenkins NA, Copeland NG. RTCGD: retroviral tagged cancer gene database. Nucleic Acids Res 2004;32:D523-7.
13. Lee CJ, Appleby VJ, Orme AT, Chan WI, Scotting PJ. Differential expression of SOX4 and SOX211 in medulloblastoma. J Neurooncol 2002;57:201-14.
14. Shin MS, Fredrickson TN, Hartley JW, Suzuki T, Agaki K, Morse HC, III. High-throughput retroviral tagging for identification of genes involved in initiation and progression of mouse splenic marginal zone lymphomas, Cancer Res 2004;64:4419-27.
15. Buaas FW, Kirsh AL, Sharma M, et al. Plzf is required in adult male germ cells for stem cell self-renewal. Nat Genet 2004;36:647-52.
16. Costoya JA, Hobbs RM, Barna M, et al. Essential role of Plzf in maintenance of spermatogonial stem cells. Nat Genet 2004;36:653-9.
17. Barat C, Rassart E. Members of the GATA family of transcription factors bind to the U3 region of Cas-Br-E and graffi retroviruses and transactivate their expression. J Virol 1998;72:5579-88.
18. Barat C, Rassart E. Nuclear factors that bind to the U3 region of two murine myeloid leukemia-inducing retroviruses, Cas-Br-E and Graffi. Virology 1998;252:82-95.
19. Lowenberg B. Prognostic factors in acute myeloid leukaemia. Best Pract Res Clin Haematol 2001;14:65-75.
20. Horrigan SK, Arbieva ZH, Xie HY, et al. Delineation of a minimal interval and identification of 9 candidates for a tumor suppressor gene in malignant myeloid disorders on 5q31. Blood 2000;95:2372-7.